AMERITAS INVESTMENT PARTNERS, INC. – Neurocrine Biosciences, Inc. Transaction History
AMERITAS INVESTMENT PARTNERS, INC. portfolio value:
$2.61M
portfolio value
AMERITAS INVESTMENT PARTNERS, INC. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.03% | -769 shares | 140K | $106.21 | 24.59K |
| Q2 2022 | share | 0.00% | 0 shares | 94K | $97.48 | 25.36K | |
| Q1 2022 | share | 0.00% | 0 shares | 218K | $93.75 | 25.36K | |
| Q4 2021 | share | Increase | +1.17% | 294 shares | -245K | $84.63 | 25.36K |
| Q3 2021 | share | Decrease | -1.89% | -484 shares | -82K | $95.91 | 25.07K |
| Q2 2021 | share | Decrease | -0.95% | -245 shares | -22K | $97.32 | 25.55K |
| Q1 2021 | share | Increase | 0.00% | 25.8K shares | 2.50M | $97.25 | 25.8K |
| Q2 2016 | share | Decrease | -100.00% | -6.66K shares | -263K | $45.45 | 0 |
| Q1 2016 | share | 0.00% | 0 shares | -114K | $39.55 | 6.66K |